Methods: A post-hoc analysis of prospectively collected data was performed on 445 patients who had a diagnosis of a dermatologic condition requiring hospitalization who were admitted to our 36 bed ABA accredited burn center over the last 10 years. These charts, divided into SJS-TEN and SD, were cross-referenced with the hospital wide infectious control database to identify patients who suffered from HAIs that met the CDC National Healthcare Safety Network surveillance definitions. These two groups were then compared using 2-tailed t-test, or chi-square, for nominal and categorical variables, respectively.
Results: There were 316 patients in the SD group and 129 in the SJS-TEN. SD patients had significantly higher ICU and ventilator days, compared to SJS-TENs. When HAI were present, both groups had a significant increase in cost, and SJS-TENs patients had increased mortality. The two cohorts did not differ, in terms of %TBSA, overall mortality, or incidence of HAI. SD patients were also significantly more likely to be female, and were more likely to have a UTI; contrasted to a CLABSI or CAUTI in the SJS-TENs group.
Conclusion: Clinicians taking care of non-SJS-TEN Skin Disorder patients in burn centers should be aware of a high mortality rate, susceptibility to similar HAI especially, and the potential for a prolonged ICU stay and high number of ventilator days. With bundled payments on the horizon, health care facilities may not be able to cover cost of care, if HAI occur in SD or SJS-TEN patients.